Research Collaboration

 
News Articles for Research Collaboration top ^
2014/9/16
Company Leverages Connectivity, Community and Insights of Ariba® Network to Fuel More Agile, Intelligent and Collaborative Supply Chain WALLDORF, Germany , Sept.
Sign-up for SAP Ushers in New Era of Collaborative Supply Chain Management investment picks
2014/11/17
http://media.marketwire.com/attachments/201210/90690_Cisco_logo.gif http://media.marketwire.com/attachments/201411/TN-81802_ciscoimage2.jpg Project Squared for team based collaboration http://media.marketwire.com/attachments/201411/TN-81803_ciscoimage1.jpg Project Squared: a place for teams to talk and share, securely http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159164&ProfileId=051205&sourceType=1 SAN JOSE, CA and LOS ANGELES, CA --
Sign-up for Cisco Unveils Project Squared: a Next-Generation, Cloud-Based Collaboration App for Team Based Collaboration investment picks
http://media.marketwire.com/attachments/201210/90710_Cisco_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159721&ProfileId=051205&sourceType=1 SAN JOSE, CA and LOS ANGELES, CA --
Sign-up for Collaboration Isn't Just for the Big Guys Anymore: Cisco Introduces Simple and Affordable Collaboration Solutions for Organizations of All Sizes investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and AbbVie Inc. (NYSE: ABBV) today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer.
Sign-up for Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology investment picks
- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones - - Companies to Jointly Develop and Commercialize Duvelisib in U.S., with Equal Profit Share; Infinity to Receive Royalties on Sales Outside the U.S. - - Infinity to Host Conference Call Today at 8:30 A.M. ET/7:30 A.M. CT - CAMBRIDGE, Mass.
Sign-up for Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology investment picks
Broad Bi-Specific Antibody Collaboration Now Includes Targets that Could Lead to New Cancer Immunotherapies INDIANAPOLIS and VANCOUVER, British Columbia , Oct.
Sign-up for Lilly, Zymeworks Announce Expansion of Strategic Licensing and Collaboration Agreement investment picks
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that 12 abstracts highlighting new clinical data on FoundationOne ® Heme will be presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition taking place December 6-9, 2014, at the Moscone Center in San Francisco.
Sign-up for Foundation Medicine and Collaborators to Present New Clinical Data on FoundationOne® Heme at the American Society of Hematology Annual Meeting investment picks
2014/11/17
Cisco and Box today announced an alliance that includes product integrations to enhance content collaboration for Project Squared , Cisco’s new business collaboration app that redefines how teams get work done.
Sign-up for Cisco and Box Team Up to Advance Enterprise Collaboration investment picks
http://media.marketwire.com/attachments/201210/90690_Cisco_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158851&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for REMINDER: Watch Cisco Collaboration Summit Keynote Live, Featuring John Chambers, Rowan Trollope and Box CEO, Aaron Levie investment picks
http://media.marketwire.com/attachments/201210/90690_Cisco_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158831&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for Watch Cisco Collaboration Summit Keynote Live, Featuring John Chambers, Rowan Trollope and Box CEO, Aaron Levie investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153048&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Pegasystems' Fourth Annual Collaborative Healthcare Summit to Highlight Performance-Driven Modernization investment picks
2014/9/18
Video collaboration is quickly becoming one of the most effective means to communicate and collaborate in business today—and healthcare is no exception.
Sign-up for Polycom’s Top Six Ways Video Collaboration is Making a Positive Impact in Healthcare investment picks
Enterprises Can Now Extend Their Telepresence and HD Video Endpoints with PGi's Crystal-Clear Audio Conferencing and Award-winning Global Customer Care ATLANTA , Nov.
Sign-up for PGi Integrates its Global Hybrid IP Audio Conferencing Network with Cisco Collaboration Meeting Rooms investment picks
2014/9/9
Optum Labs, the collaborative research and innovation center co-founded by Optum and Mayo Clinic, announced the addition of four new partners committed to improving the quality and value of patient care.
Sign-up for Four New Partner Organizations Join Optum Labs Research Collaborative investment picks
Stratasys Ltd .
Sign-up for Stratasys to Acquire GrabCAD, a Leading 3D CAD Collaboration Platform investment picks
2014/9/24
Genzyme , a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the establishment of a research collaboration with the University of Florida and the University of Pennsylvania to develop a gene therapy for the treatment of a rare genetic disease that causes childhood blindness.
Sign-up for Genzyme Collaborates on Gene Therapy for Rare Disease that Causes Childhood Blindness investment picks
NanoString Technologies, Inc.(NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has signed a multi-year, multi-investigator research collaboration with Harvard-affiliated Brigham and Women’s Hospital to accelerate the translation of genomic biomarker discoveries into clinical cancer diagnostics.
Sign-up for NanoString Collaborates with Brigham and Women’s Hospital in Boston to Accelerate Translation of Genomic Discoveries into Clinical Diagnostics in Oncology investment picks
2014/10/13
Now available for all businesses that want to empower their employees with robust collaboration tools, Sprint (NYSE: S) is offering a mobile-centric solution of Google Apps for Work.
Sign-up for Mobile Collaboration Just Got Easier with Sprint and Google Apps for Work investment picks
> The collaboration will result in a novel, next-generation sequencing based panel for the improved diagnosis and prognosis of Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) > Nearly 100,000 people are living with MDS in the US, and both MDS and AML are increasing globally in incidence and prevalence.
Sign-up for Cancer Genetics Inc. Announces Collaboration With Leading Oncology Researchers at Columbia University to Identify Genomic Signatures, Biomarkers and Novel Treatments for MDS and AML investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Collaboration
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Clients  |  Next: Research Communities